Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Cancer Mutation Consortium Protocol

NCT01014286 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01014286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01014286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Cancer Mutation Consortium Protocol
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Completed
Start date
September 16, 2009
Completion date
January 12, 2019
Enrollment
1,100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of lung, stage iv